Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-054657
Filing Date
2020-11-19
Accepted
2020-11-19 16:30:10
Documents
98
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdak-10q_20200930.htm 10-Q 3764591
2 EX-31.1 cdak-ex311_11.htm EX-31.1 19940
3 EX-31.2 cdak-ex312_10.htm EX-31.2 20154
4 EX-32.1 cdak-ex321_8.htm EX-32.1 17235
  Complete submission text file 0001564590-20-054657.txt   13475458

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cdak-20200930.xml EX-101.INS 2872428
6 XBRL TAXONOMY EXTENSION SCHEMA cdak-20200930.xsd EX-101.SCH 108983
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdak-20200930_cal.xml EX-101.CAL 78902
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdak-20200930_def.xml EX-101.DEF 368162
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdak-20200930_lab.xml EX-101.LAB 742780
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdak-20200930_pre.xml EX-101.PRE 590185
Mailing Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104
Business Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104 857-400-4222
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39615 | Film No.: 201329152
SIC: 2836 Biological Products, (No Diagnostic Substances)